Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1955 2
1956 2
1960 1
1961 3
1963 1
1970 1
1981 1
1985 2
1989 1
1995 1
1999 1
2000 1
2001 2
2002 2
2003 3
2005 3
2006 3
2007 4
2008 7
2009 7
2010 2
2011 3
2012 8
2013 13
2014 7
2015 9
2016 9
2017 7
2018 13
2019 14
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Results by year
Filters applied: . Clear all
Page 1
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy.
Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, Yamamoto Y, Nakamura T, Inatomi T, Bush J, Toda M, Hagiya M, Yokota I, Teramukai S, Sotozono C, Hamuro J. Kinoshita S, et al. N Engl J Med. 2018 Mar 15;378(11):995-1003. doi: 10.1056/NEJMoa1712770. N Engl J Med. 2018. PMID: 29539291 Free article. Clinical Trial.
Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction.
Okumura N, Sakamoto Y, Fujii K, Kitano J, Nakano S, Tsujimoto Y, Nakamura S, Ueno M, Hagiya M, Hamuro J, Matsuyama A, Suzuki S, Shiina T, Kinoshita S, Koizumi N. Okumura N, et al. Sci Rep. 2016 May 18;6:26113. doi: 10.1038/srep26113. Sci Rep. 2016. PMID: 27189516 Free PMC article.
127 results
Jump to page
Feedback